Agenda for Day 2 - Wednesday August 12th, 2026Wednesday, 12 August 2026 - EST/EDT (Eastern Daylight, GMT-4)

Showing 1 of 1 Streams

Networking Break

8:30am - 9:00am

Networking Breakfast

Showing 3 of 3 Streams

HCP Engagement & Quality

Compliance Monitoring & Risk Management

Data Governance & Reporting

9:00am - 9:15am

Track Chair Kick-Off

Dawn DiPierro - Director of Global Compliance Operations, Insmed

9:15am - 10:00am

Reimagining Speaker Programs — Design High-Value, High-Impact Engagements

Explore how companies are reevaluating speaker program design to balance educational value, compliance expectations and appropriate utilization
Gain perspectives on emerging expectations around documentation, rationale and oversight as scrutiny on these programs continue to increase

Micah Ackerman - Director, Compliance Business Partner, Boehringer Ingelheim
Erik Gross - Compliance Specialist, Novartis

10:00am - 10:45am

Modern HCP Engagement Systems — Optimization, Enhancements & Interactive Q&A

This session is meant to be a follow-up to the Modern HCP Engagement Systems session from Day 1, where participants can take a deeper dive, participate in an interactive Q&A focused on real‑world challenges, audience questions, and practical approaches to strengthening HCP engagement operations
Interact with peers and share what is working and what other companies have done to strengthen their HCP Engagement systems through automation and AI
Examine system scalability, integration considerations, and emerging enhancements and AI-enabled features

Dawn DiPierro - Director of Global Compliance Operations, Insmed

9:00am - 9:15am

Track Chair Kick-Off

Christian Richardson - Director of Compliance, Celltrion USA

9:15am - 10:00am

Improving Operational Efficiency for Streamlined Reporting and Monitoring

Examine how teams are rethinking processes, workflows and cross-functional alignment to support timely, accurate and resource-efficient transparency operations
Review strategies for optimizing approval pathways, strengthening communications with business partners and reducing manual rework
Explore how different tools and process simplifications can drive consistency while allowing compliance teams to focus on higher-value activities

Rabail Ali - Product Leader | Transparency Reporting Solution, qordata
Shane White - Director, Compliance, Integra
Sulay Desai - Senior Manager, Compliance Operations, ConvaTec

10:00am - 10:45am

Predictive Analytics for Compliance—Building AI-Driven Monitoring Frameworks

Explore how compliance teams are beginning to use predictive analytics and machine learning to identify engagement risks earlier and more accurately
Review practical applications for AI, including anomaly detection, pattern recognition and prioritization of higher-risk activities or documentation gaps
Discuss considerations for implementation, governance and cross-functional collaboration to ensure AI-driven monitoring supports

Björn Dupre - Director of Compliance Monitoring & Investigations, Bayer
Sara Merin - Senior Assistant General Counsel, US Office of Ethics & Compliance, Bayer

9:00am - 9:15am

Track Chair Kick-Off

Tim Abbott - Associate Director of Global Compliance Systems and Data Analytics, BeOne Medicines

9:15am - 10:00am

Data Integrity Under Pressure—Ensuring Accuracy in Aggregate Spend

Examine the leading sources of data discrepancies, including upstream errors, manual edits and inconsistent documentation that directly impacts aggregate spend reporting
Review practical methods for improving data checks, reducing manual corrections and ensuring consistent, accurate data flows from all business functions
Discuss process and governance enhancements that help teams maintain data integrity even during restrictive timelines or high-volume reporting periods

Caitlin Oroho - Manager, Global Compliance, PTC Therapeutics, Inc.
Dan LaVallee - Director of Transparency Reporting, Genmab
Jason DiPietro - Senior Manager, Compliance Data Analytics and Transparency Reporting, Lundbeck US

10:00am - 10:45am

Data Privacy and Access Controls in AI Adoption

Explore how organizations are integrating data privacy and access controls into AI-supported processes, ensuring compliance with internal standards and external regulations
Review considerations for limiting unnecessary data exposure, controlling who can access sensitive information and ensuring AI tools use data responsibly

Nereida Parks - Regional AI, HIPAA, Privacy Officer, OCA, Olympus Corporation

Showing 1 of 1 Streams

Networking Break

10:45am - 11:15am

Networking & Refreshment Break

Showing 3 of 3 Streams

HCP Engagement & Quality

Compliance Monitoring & Risk Management

Data Governance & Reporting

11:15am - 12:00pm

Fair Market Value 2.0—Practical Approaches for a More Complex Engagement Landscape

Examine how companies are navigating FMV challenges across speaking, consulting and advisory engagements as expectations around justification and documentation continue to increase
Discuss practical approaches to improving rate consistency, strengthening rationale, and supporting audit readiness
Explore how organizations are enhancing FMV processes to balance risk management with operational efficiency

Tim Roberts - Former Chief Compliance Officer, Legend Therapeutics
Rachael Kopeck - Director of Compliance & Ethics, Penumbra

12:00pm - 12:45pm

Smarter KOL Tiering and Identification—Data-Driven Approaches for Today’s Environment

Explore updated methods for identifying, evaluating and tiering HCPs
Discuss how organizations use data and analytics to support more objective and consistent tiering decisions
Hear best practices for creating consistent, scalable tiering frameworks across commercial and medical teams

Maria Villanueva - Director, Ethics & Compliance, BioTissue

11:15am - 12:00pm

From Evaluation to Approval – How Compliance Leaders Select and Champion New Tools

Explore how senior compliance and transparency leaders evaluate new tools and service providers, including the criteria used to assess risk, value, scalability, and organizational fit
Examine how initiatives are championed internally, the stakeholders involved in approvals, and the factors that influence whether proposals gain momentum or stall
Discuss what internal teams and vendors need to demonstrate beyond functionality to build a compelling, leadership‑ready case that secures final sign‑off

Aisha Ghazi Babar - General Counsel, Chief Compliance Officer & Corporate Secretary, Pierre Fabre
Karen Lowney - Head of Ethics & Compliance, Sun Pharmaceutical

12:00pm - 12:45pm

Monitoring Field Interactions—Strengthening Accuracy, Documentation and Issue Detection

Review approaches for monitoring field-based activities, including speaker program execution, HCP interactions and meal distribution practices
Examine common documentation challenges and how clearer guidance, standardized tools and ongoing training can help field teams stay current with evolving requirements
Discuss methods for identifying issues earlier, improve escalation pathways and provide real-time feedback to reduce reporting risks

Björn Dupre - Director of Compliance Monitoring & Investigations, Bayer
Christian Richardson - Director of Compliance, Celltrion USA
Jamie Lutz - Associate Director, U.S. Compliance Monitoring, Gilead Sciences

11:15am - 12:00pm

Managing Third-Party Vendors—Oversight, Accountability and Data Quality

Learn the best practices for overseeing third-party vendors involved in data collection, HCP identification, system integration and transparency reporting
Examine approaches for evaluating vendor performance, documenting shared responsibilities and ensuring data accuracy across complex multi-vendor ecosystems
Discuss strategies for strengthening accountability, improving communication pathways and mitigating operational risks, particularly for small and midsize companies with limited internal resources

Patrick Thibodeau - Senior Compliance Manager, Kyowa Kirin, Inc.
Brenda Crabtree - Senior Director of Commercial Legal & Compliance, Kura Oncology

12:00pm - 12:45pm

HCP Master Data—Reducing Duplicates, Contradictions, and Identification Challenges

Review common master data challenges, including duplications, conflicting records and incomplete HCP profiles that complicate downstream reporting
Explore methods for strengthening HCP identification through validation rules, data cleansing and technology-enabled matching
Discuss how improved data governance and stronger cross-functional coordination support more accurate, reliable HCP master data management

Inge Tham - Senior Manager, HCP Transparency Reporting, Edwards Lifesciences
Jaime Melendez - Enterprise Data and AI Governance, CSL

Showing 1 of 1 Streams

Networking Break

12:45pm - 1:45pm

Networking Luncheon

Showing 3 of 3 Streams

HCP Engagement & Quality

Compliance Monitoring & Risk Management

Data Governance & Reporting

1:45pm - 2:30pm

Strategic Spending and Waste Reduction—Ensuring the Right HCP Engagements

Examine how companies are assessing field interactions, meal spend, and speaker utilization to identify low-value engagement patterns
Explore approaches for improving targeting, reallocating resources more effectively and enhancing both educational and strategic value
Gain insights into emerging expectations around spend management as financial pressures increase

Peter Lee - Vice President, Chief Compliance Officer, Kura Oncology

2:30pm - 3:15pm

Designing for Scrutiny — How HCP Engagement Decisions Upstream Drive Transparency Risk Downstream

Examine how decisions made during HCP engagement design, including who is engaged, at what frequency, at what value, and with what rationale, directly shape an organization’s transparency exposure and reporting risk
Explore common upstream engagement patterns that create downstream compliance vulnerabilities and discuss how teams can build more defensible, audit-ready programs from the start
Discuss practical approaches for aligning HCP engagement strategy with transparency and reporting requirements, ensuring that compliance considerations are embedded early rather than addressed after the fact

1:45pm - 2:30pm

Issue Management and Internal Controls—Building a More Proactive Risk Frameworks

Explore how organizations strengthen issue identification, escalation, and remediation processes to support more proactive and transparent risk management
Review approaches for developing internal controls, particularly for small and midsize biopharma teams with limited resources and infrastructure

Eleni Farrell - US Compliance Business Partner, Insmed
Aisha Ghazi Babar - General Counsel, Chief Compliance Officer & Corporate Secretary, Pierre Fabre

2:30pm - 3:15pm

Risk Signals and Early Indicators—Detecting Audit Issues Before They Emerge

Examine key patterns and data signals that often precede audit findings, errors, or compliance concerns across transparency and HCP engagement activities
Explore practical early-warning tools and monitoring approaches that are adaptable for both large organizations and smaller biopharma teams without advanced systems
Discuss how timely detection, targeted escalation and structured review cycles can strengthen audit readiness and reduce downstream risks

Eric Jen - Director of Compliance, Cytokinetics Inc
Poonam Maharjan - Director, Ethics & Compliance, Lantheus

1:45pm - 2:30pm

System Integrations and M&A Complexity—Managing Data During Organizational Change

Examine how mergers, acquisitions, and system consolidations affect data consistency and transparency reporting readiness
Review strategies for managing integrations finance, commercial operations, medical affairs and IT to reduce disruptions and reporting gaps
Discuss practical steps for maintaining data integrity during transitions, including validation processes and cross-functional coordination

Brenda Crabtree - Senior Director of Commercial Legal & Compliance, Kura Oncology
Patrick Thibodeau - Senior Compliance Manager, Kyowa Kirin, Inc.
Erik Gross - Compliance Specialist, Novartis

2:30pm - 3:15pm

[Case Study] Building a Resilient Aggregate Spend & HCP Engagement Data Ecosystem

Explore how Corcept Therapeutics built a high resilience, end to end aggregate spend and HCP engagement data ecosystem designed to withstand organizational changes, new data flows, and evolving transparency requirements
Hear firsthand how the system captures speaker programs, HCP interactions, contracting data, expenses, touchpoints and real time changes with minimal disruption and exceptionally strong data integrity
Learn how the team designed future proof workflows that can scale with business growth, absorb process changes and maintain reporting accuracy even during periods of restructuring or evolving operational models

Ben McKinley - Associate Director, Transparency & Compliance, Corcept Therapeutics Inc

Showing 1 of 1 Streams

Networking Break

3:15pm - 3:45pm

Networking & Refreshment Break

Showing 1 of 1 Streams

General Session

3:45pm - 4:30pm

AI and Automation in Reporting—Practical Use Cases for Efficiency and Accuracy

Explore how companies are applying AI and automation to streamline data processing, reduce manual workload, improve reporting timelines, and identify anomalies earlier in the transparency lifecycle.
Examine real‑world examples of automated workflows, machine learning models, and anomaly‑detection tools that enhance data quality, strengthen audit readiness, and improve downstream reporting accuracy.
Discuss governance and oversight considerations, including data privacy safeguards, model transparency, role‑based access, and responsible AI adoption to ensure automated tools support, not replace critical compliance decision‑making

Charles de Gaspe Beaubien - Founder and Chief Commercial Officer, Groupize
Vishal Khapane - Senior Director, External Expert Engagement Services, AstraZeneca

4:30pm - 5:15pm

The Future of Integrated Transparency – Aligning Compliance, Data, and Engagement in a Converging Landscape

Explore how transparency, HCP engagement, data governance, and monitoring functions are converging and what this means for future organizational structures, ownership models, and cross‑functional collaboration
Examine emerging expectations from regulators, business partners, and external stakeholders, and how companies are rethinking processes, systems, and decision frameworks to prepare for the next phase of transparency evolution
Discuss the long‑term capabilities organizations must build, including data literacy, agile workflows, and AI‑ready governance, to stay ahead in an increasingly complex and integrated compliance environment

Leah Osowski - Director, Transparency Reporting, Americas, Johnson & Johnson
Tim Abbott - Associate Director of Global Compliance Systems and Data Analytics, BeOne Medicines
Saron Djergna - Global Manager, Risk Management, Training, & Transparency, Teleflex

Showing 1 of 1 Streams

Networking Break

5:15pm - 6:15pm

Close of Day Two and Networking Reception